Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tacrolimus”

862 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 862 results

Post-approval studies (Phase 4)Study completedNCT00982072
What this trial is testing

Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease

Who this might be right for
Minimal Change Disease
Imperial College Healthcare NHS Trust 52
Not applicableStudy completedNCT01910077
What this trial is testing

Bioequivalence Study of Tacrobell Capsule 1mg to Prograf Capsule 1mg

Who this might be right for
Immunosuppression
Chong Kun Dang Pharmaceutical 50
Large-scale testing (Phase 3)Looking for participantsNCT07412470
What this trial is testing

Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation

Who this might be right for
Kidney Transplant Rejection
Sanofi 526
Large-scale testing (Phase 3)Study completedNCT01187953
What this trial is testing

Double-Blind,Double-Dummy,Efficacy/Safety,LCP-Tacro™ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney Tx

Who this might be right for
Renal Failure
Veloxis Pharmaceuticals 543
Testing effectiveness (Phase 2)Study completedNCT00003572
What this trial is testing

Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Large-scale testing (Phase 3)Study completedNCT00382109
What this trial is testing

Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission

Who this might be right for
B-cell Childhood Acute Lymphoblastic LeukemiaChildhood Acute Lymphoblastic Leukemia in RemissionGraft Versus Host Disease+3 more
Children's Oncology Group 146
Not applicableStudy completedNCT01887171
What this trial is testing

Evaluation of Preimplantation Portal Vein and Hepatic Artery Flushing With Tacrolimus

Who this might be right for
Early Allograft DysfunctionIschemic Reperfusion InjuryLiver Transplantation+1 more
Republican Scientific and Practical Center for Organ and Tissue Transplantation 86
Post-approval studies (Phase 4)Study completedNCT03347357
What this trial is testing

Pharmacokinetics of Tacrolimus in Children

Who this might be right for
Nephrotic Syndrome
Shandong University 28
Testing effectiveness (Phase 2)WithdrawnNCT04263519
What this trial is testing

A Pilot Open Labeled Study of Tacrolimus in Alzheimer's Disease.

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
Massachusetts General Hospital
Large-scale testing (Phase 3)Study completedNCT00865137
What this trial is testing

An Open Study Assessing Bioavailability of a Modified Formulation of Tacrolimus in Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 27
Testing effectiveness (Phase 2)Ended earlyNCT00282230
What this trial is testing

Evaluate the Safety and Efficacy of Prograf/FK778 and Prograf/MMF in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 150
Post-approval studies (Phase 4)Study completedNCT00629122
What this trial is testing

Pharmacokinetics of Sublingual Versus Oral Tacrolimus in Patients Awaiting Kidney Transplantation

Who this might be right for
Kidney Failure, Chronic
Weill Medical College of Cornell University 5
Large-scale testing (Phase 3)Study completedNCT00720265
What this trial is testing

Assess the Safety and Efficacy of Prograf and MR4 in Kidney Transplantation Patients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 135
Post-approval studies (Phase 4)Study completedNCT01744067
What this trial is testing

The Effects of Omega-3 Fatty Acids in Renal Transplantation

Who this might be right for
Disorder Related to Renal Transplantation
Oslo University Hospital 132
Testing effectiveness (Phase 2)Study completedNCT01332201
What this trial is testing

Study to Compare the Pharmacokinetics of Tacrolimus in Adult Transplant Recipients Treated With Advagraf® or Prograf®

Who this might be right for
Heart TransplantationLung TransplantationPancreas (Including SPK) Transplantation
Astellas Pharma Inc 17
Post-approval studies (Phase 4)UnknownNCT00166816
What this trial is testing

The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant Patients

Who this might be right for
TransplantationKidney TransplantationImmunosuppression
National Taiwan University Hospital 40
Post-approval studies (Phase 4)UnknownNCT00564538
What this trial is testing

Thymoglobulin and Tacrolimus in Liver Transplant

Who this might be right for
Liver TransplantationLiver DiseaseImmunosuppression
University of Nebraska 100
Post-approval studies (Phase 4)Study completedNCT04838288
What this trial is testing

Cognitive Outcomes in Stable Renal Transplant Patients Switched fromTacrolimus to Envarsus XR™

Who this might be right for
Renal Transplant
Vanderbilt University Medical Center 56
Post-approval studies (Phase 4)Study completedNCT00296296
What this trial is testing

Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)

Who this might be right for
Kidney TransplantDiabetes Mellitus, Type 2Diabetic Nephropathy
Stanford University 29
Large-scale testing (Phase 3)Study completedNCT00567762
What this trial is testing

Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis

Who this might be right for
KeratoconjunctivitisConjunctivitis
Astellas Pharma Inc 56
Next Page